After Outstanding Q2 Results, This Pot Stock Is Ready to Bloom

After Outstanding Q2 Results, This Pot Stock Is Ready to Bloom
·4 min read

Cannabis stocks have fallen from their February highs, in part because investors did not see as much movement in cannabis reform as they had anticipated. The industry benchmark, the Horizons Marijuana Life Sciences ETF is down 6% so far this year compared to the S&P 500's surge of 19%. One such MSO is Illinois-based Cresco Labs (OTC: CRLBF), which has grown its revenue dramatically by expanding in key markets that offer limited licenses.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting